Last week, the United States Food and Drug Administration (FDA) revoked the Emergency Use Authorization for Johnson & Johnson coronavirus shots. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, noted in a Thursday letter that the FDA made the revocation at the request of Janssen Biotech, a Johnson & Johnson subsidiary, that had related that the company would not be updating its shots, the latest “lots” purchased by the US government have expired, and “there is no demand for new lots.”
The lack of demand is little surprise. Americans have increasingly became hip to the fact that Johnson & Johnson’s shots, along with those of other companies such as Moderna and Pfizer-BioNTech, are dangerous and ineffective. This is in contrast with the relentless sales pitch from shots promotors in government and media that the shots were safe and effective. Successive court decisions, followed by withdrawal of much of the remaining US coronavirus shots mandates by the Biden administration have further reduced demand by removing much of the mandates to which Americans have been subjected.
All along, Johnson & Johnson has apparently been singled out by the US government for harsher treatment than other companies engaged in the American coronavirus shots campaign. I have written about this situation in previous posts:
FDA Says Stop the Johnson & Johnson Coronavirus Vaccine Shots” on April 13, 2021
If Johnson & Johnson Coronavirus Vaccine Shots Are Halted Because of Blood Clots, Why Have Moderna and Pfizer-BioNTech Shots Not Also Been Halted?” on April 17, 2021
‘Teacher’s Pets’ Moderna and Pfizer-BioNTech Again Avoid FDA Scrutiny” on July 15, 2021
Propaganda Master Anthony Fauci” on December 17, 2021
FDA Again Singles Out Johnson & Johnson Coronavirus Shot for Danger Warning” on January 13, 2022
Eliminating Competition: The FDA Further Restricts Use of Johnson & Johnson Coronavirus shots” on May 6, 2022
